Home Cart Sign in  
Chemical Structure| 1456632-40-8 Chemical Structure| 1456632-40-8

Structure of SH-4-54
CAS No.: 1456632-40-8

Chemical Structure| 1456632-40-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SH-4-54 is a potent, small molecule, nonphosphorylated STAT3 inhibitor with KD of 300 nM and 464 nM for STAT3 and STAT5, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SH-4-54

CAS No. :1456632-40-8
Formula : C29H27F5N2O5S
M.W : 610.59
SMILES Code : O=C(O)C1=CC=C(N(CC2=CC=C(C3CCCCC3)C=C2)C(CN(C)S(=O)(C4=C(F)C(F)=C(F)C(F)=C4F)=O)=O)C=C1
MDL No. :MFCD28143917
InChI Key :VFPYGNNOSJWBHF-UHFFFAOYSA-N
Pubchem ID :72188643

Safety of SH-4-54

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SH-4-54

JAK-STAT

Isoform Comparison

Biological Activity

Target
  • STAT3

    STAT3, Kd:300 nM

  • STAT5

    STAT5, Kd:464 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
LX-2 cells 0.3 µM 48 hours Inhibited LX-2 cell viability, IC50 of 0.37 µM PMC6032316
HSC-T6 cells 0.3 µM 48 hours Inhibited HSC-T6 cell viability, IC50 of 0.46 µM PMC6032316
SK-N-AS neuroblastoma cells 5 μM 72 hours SH-4-54 alone had insignificant effects on cell proliferation, migration, and apoptosis in SK-N-AS cells, but significantly enhanced the anti-proliferative and anti-migratory effects of Cetuximab when used in combination. PMC6804809
UBE4B-depleted SK-N-AS neuroblastoma cells 5 μM 72 hours In UBE4B-depleted SK-N-AS cells, SH-4-54 significantly potentiated the effect of Cetuximab, increasing the cells' sensitivity to Cetuximab. PMC6804809
Panc10.05 8.7 ± 1.9 μM 72 hours To evaluate the inhibitory effect of SH-4-54 on the proliferation of Panc10.05 cells, the results showed an ED50 value of 8.7 ± 1.9 μM for SH-4-54. PMC4873422
Pa03C 9.2 ± 1.7 μM 72 hours To evaluate the inhibitory effect of SH-4-54 on the proliferation of Pa03C cells, the results showed an IC50 value of 9.2 ± 1.7 μM for SH-4-54. PMC4873422
CAF19 7.6 ± 0.9 μM 72 hours To evaluate the inhibitory effect of SH-4-54 on the proliferation of CAF19 cells, the results showed an IC50 value of 7.6 ± 0.9 μM for SH-4-54. PMC4873422
U87 10 μM 48 hours inhibit STAT3 phosphorylation, activate pyroptosis, and reduce cell proliferation PMC11284224
LN229 10 μM 48 hours inhibit STAT3 phosphorylation, activate pyroptosis, and reduce cell proliferation PMC11284224

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice Pancreatic cancer xenograft model Intraperitoneal injection 10 mg/kg Single injection To evaluate the anti-tumor effect of SH-4-54 on the pancreatic cancer xenograft model, the results showed that SH-4-54 significantly inhibited tumor growth, with a 54-62% reduction in tumor volume. PMC4873422
Mice LGL1SMKO mice 1 nM–10 µM Lifelong supplementation SH-4-54 attenuated neointimal hyperplasia in LGL1SMKO mice. PMC8819082
BALB/c-nude mice PC-9 L792Fcis xenografts Oral 10 mg/kg Once daily for 15 days Inhibiting STAT3, restoring sensitivity to osimertinib, and suppressing tumor growth PMC9358434

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.64mL

0.33mL

0.16mL

8.19mL

1.64mL

0.82mL

16.38mL

3.28mL

1.64mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories